AdvaMed Comments on Docket No. FDA-2017-D-6294: Changes to Existing Medical Software Policies Resulting From Section 3060 of the 21st Century Cures Act; Draft Guidance for Industry and Food and Drug Administration Staff
Comments
application/pdf
- 442.39 kB
Date:
02/06/2018 Issues: